12.07.2015 Views

Print ACNR MJ05 v4 - Advances in Clinical Neuroscience and ...

Print ACNR MJ05 v4 - Advances in Clinical Neuroscience and ...

Print ACNR MJ05 v4 - Advances in Clinical Neuroscience and ...

SHOW MORE
SHOW LESS
  • No tags were found...

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Journal ReviewsMIGRAINE: cortical hyperexcitability between episodesIt is known that visual process<strong>in</strong>g between migra<strong>in</strong>e attacks is abnormal, <strong>and</strong>we see this <strong>in</strong> some migra<strong>in</strong>eurs who are constantly sensitive to light <strong>and</strong> certa<strong>in</strong>patterns. (One of my colleagues owns a diagnostic patterned tie whichmigra<strong>in</strong>eurs object to, <strong>and</strong> others simply tolerate). Whether this phenomenonis due to cortical hyper- or hypoexcitability was the subject of this <strong>in</strong>terest<strong>in</strong>gstudy. Twenty migra<strong>in</strong>eurs <strong>and</strong> twenty controls were compared <strong>in</strong> theirmotion perception thresholds <strong>in</strong> two sett<strong>in</strong>gs: responses to coherent mov<strong>in</strong>gdots presented <strong>in</strong> an <strong>in</strong>coherent <strong>and</strong> then a coherent environment. Theresults were that migra<strong>in</strong>eurs performed better than controls <strong>in</strong> the coherentenvironment (with high signal to noise ratio) <strong>and</strong> worse <strong>in</strong> the <strong>in</strong>coherentenvironment. It is suggested that several neuronal encod<strong>in</strong>g patterns <strong>in</strong> adef<strong>in</strong>ed cortical area <strong>in</strong> migraneurs may be activated dur<strong>in</strong>g a noisy task,while a distraction free task allows a small focused area of activation.Excessive excitation due to abnormal release of excitatory neurotransmittersmay be a factor <strong>in</strong> this <strong>and</strong> is supported by the f<strong>in</strong>d<strong>in</strong>g of higher plasma levelsof glutamate <strong>in</strong> migra<strong>in</strong>eurs. It has also been suggested that repeatedepisodes of cortical spread<strong>in</strong>g depression may result <strong>in</strong> suppression or damageto GABAergic <strong>in</strong>hibitory function. Alternatively it has been suggestedthat cortical hyperexcitability may cause migra<strong>in</strong>eurs to be vulnerable to corticalspread<strong>in</strong>g depression. It seems clear that the central factors <strong>in</strong> migra<strong>in</strong>eare complex <strong>and</strong> as yet poorly understood. – HA-LAntal A, Temme J, Nitsche MA, Varga ET, Lang N, Paulus W.Altered motion perception <strong>in</strong> migra<strong>in</strong>eurs: evidence for <strong>in</strong>terictal corticalhyperexcitability.CEPHALALGIA2005;25:788-94.STROKE: A help<strong>in</strong>g h<strong>and</strong> to help a h<strong>and</strong>Can you pat your head <strong>and</strong> rub your tummy at the same time? Many peoplef<strong>in</strong>d this difficult <strong>and</strong> end up do<strong>in</strong>g the same action with both h<strong>and</strong>s. This isbecause the motor system has a strong tendency towards synchrony. There hasbeen <strong>in</strong>terest <strong>in</strong> exploit<strong>in</strong>g this tendency <strong>in</strong> retra<strong>in</strong><strong>in</strong>g arm movements <strong>in</strong>stroke patients. But the question is: Would the affected arm improve its movement<strong>in</strong> l<strong>in</strong>e with the non-paretic side or would its performance deteriorate?There have been a number of small n k<strong>in</strong>ematic studies look<strong>in</strong>g at strokepatients’ movements us<strong>in</strong>g one arm or both at the same time. Results have beenconflict<strong>in</strong>g; some have found improved performance of the affected limb <strong>in</strong>bilateral movements while others have found its movement quality is degraded.Us<strong>in</strong>g a larger group of thirty-two chronic stroke patients with moderatehemiparesis, Harris-Love et al have analysed the k<strong>in</strong>ematics of arm movements<strong>in</strong> bilateral <strong>and</strong> unilateral reach<strong>in</strong>g movement conditions. They also <strong>in</strong>vestigatedthe effect of load<strong>in</strong>g the non-paretic arm to see if the <strong>in</strong>creased effort neededto move the non-paretic arm would trigger <strong>in</strong>creased activation of theparetic arm. The patients were asked to reach forward across a table towards abox as fast as possible. The non-paretic limb was loaded with weights rang<strong>in</strong>gfrom 5-20% of the maximum strength of the shoulder flexors. K<strong>in</strong>ematic datawas captured us<strong>in</strong>g a magnetic track<strong>in</strong>g system <strong>and</strong> peak velocity, peak acceleration<strong>and</strong> total movement times were calculated. The paretic arm achievedhigher peak velocity <strong>and</strong> acceleration <strong>in</strong> the bilateral condition, althoughmovement time was not significantly different from when the reach was performedunilaterally. No further improvement was ga<strong>in</strong>ed by weight<strong>in</strong>g thenon-paretic arm. It seems that perform<strong>in</strong>g the movement bilaterally at leastimproves activation of the ballistic phase of reach<strong>in</strong>g. This makes sense s<strong>in</strong>ce itis known from anatomical studies <strong>and</strong> from transcranial magnetic stimulationstudies that the proximal muscles are strongly <strong>in</strong>fluenced by bilateral projections.Encourag<strong>in</strong>g bilateral movements could be a useful strategy to facilitateearly recovery of arm movements. There have been some encourag<strong>in</strong>g resultsso far. It will be <strong>in</strong>terest<strong>in</strong>g to see if, when tested us<strong>in</strong>g a r<strong>and</strong>omised controlledtrial, these effects translate to long last<strong>in</strong>g improvements <strong>in</strong> function. – AJTHarris-love ML, McCombe Waller S, Whitall J.Exploit<strong>in</strong>g <strong>in</strong>terlimb coupl<strong>in</strong>g to improve paretic arm reach<strong>in</strong>g performance<strong>in</strong> people with chronic stroke.ARCHIVES PHYSICAL MEDICINE AND REHABILITATION2005; 86: 2131-7.EPILEPSY: What difference does a neurologist make?The authors contacted all patients with possible or def<strong>in</strong>ite epilepsy <strong>in</strong> theWrexham catchment area, identify<strong>in</strong>g them from GP records of diagnosis oranti-epileptic drug <strong>in</strong>take. In a population of 200,000, they excluded 183 childrenunder 16 <strong>and</strong> 123 over 80. They also excluded 357 adults already attend<strong>in</strong>gan epilepsy cl<strong>in</strong>ic, leav<strong>in</strong>g 275 patients. Only 53 (19%) had previouslybeen seen by a neurologist. Each patient was seen <strong>and</strong> classified as def<strong>in</strong>ite ordoubtful epilepsy. Prevalence of epilepsy was 0.69% - very similar to otherstudies. Overall remission rate was around 60%, similar for neurologists <strong>and</strong>non-specialists (Perhaps we should all go home). Misdiagnosis rate was 16%,similar to the one fifth of patients misdiagnosed <strong>in</strong> many hospital based studies<strong>in</strong> the last 20 years. For patients seen by neurologists, the misdiagnosisrate was 5.6% compared to 19.3% for patients diagnosed by non-specialists.For 87 patients (one third) they felt there were sufficient grounds to recommendspecialist follow-up. In 17 patients a long-term remission was achievedby adjust<strong>in</strong>g the dose of medication or chang<strong>in</strong>g the treatment. Ten of thesewere focal <strong>and</strong> 6 idiopathic generalised epilepsies, with one symptomaticgeneralised epilepsy. In this cohort, few of whom had previously seen a neurologist,a full cl<strong>in</strong>ical assessment led to a major change <strong>in</strong> diagnosis or treatment<strong>in</strong> about 20% of patients. So neurologists do seem to do better thannon-neurologists <strong>and</strong> the study shows the size of the unmet need of patients<strong>in</strong> the community who suffer cont<strong>in</strong>u<strong>in</strong>g seizures, <strong>and</strong> could either be rediagnosedor treated better if they were seen by specialists. The challenge isto f<strong>in</strong>d ways of develop<strong>in</strong>g services to deal with this when neurologists arestill quite th<strong>in</strong> on the ground. - MRAMLeach JP, Lauder R, Nicolson A, Smith DF.Epilepsy <strong>in</strong> the UK: Misdiagnosis, mistreatment <strong>and</strong> undertreatment? TheWrexham area epilepsy project.SEIZURE2005;14:514-20.NEUROGENESIS: Forget Atk<strong>in</strong>s, try CNTFWWW RECOMMENDEDNeurogenesis, as <strong>ACNR</strong> readers are probably now aware, occurs constitutively<strong>in</strong> the adult mammalian CNS <strong>in</strong> the subventricular zone (SVZ) <strong>and</strong> thedentate gyrus (DG) of the hippocampus. Constitutive neurogenesis mayoccur elsewhere <strong>in</strong> the bra<strong>in</strong> but this is difficult to detect us<strong>in</strong>g current methodsof labell<strong>in</strong>g of newborn cells. Newborn cells are labelled us<strong>in</strong>g bromodeoxyurid<strong>in</strong>e(BrdU), a thymid<strong>in</strong>e analogue which b<strong>in</strong>ds to cells undergo<strong>in</strong>gdivision. Kokoeva, Y<strong>in</strong> <strong>and</strong> Flier have <strong>in</strong>fused BrdU cont<strong>in</strong>uously for 7 days<strong>in</strong>to the ventricles of adult mice, <strong>and</strong> this labels more divid<strong>in</strong>g cells than thenormal, less frequent adm<strong>in</strong>istration protocols. As a consequence, BrdU-positivecells were found <strong>in</strong> the hypothalamus, particularly <strong>in</strong> the arcuate nucleus,<strong>and</strong> the cells were unlikely to have migrated from the SVZ. Thus, neurogenesismay play a role <strong>in</strong> hypothalamic function. Ciliary neurotrophic factor(CNTF) is known to <strong>in</strong>duce weight loss that is, unlike most other agents, susta<strong>in</strong>ed<strong>in</strong> the long term. An <strong>in</strong>fusion of CNTF was found to <strong>in</strong>crease the numberof BrdU-positive cells <strong>in</strong> the hypothalamus, particularly <strong>in</strong> areas perta<strong>in</strong><strong>in</strong>gto feed<strong>in</strong>g control. Newborn cells expressed CNTF receptors; around 50%expressed neuronal markers <strong>and</strong> around 20% oligodendrocyte markers. Thenewborn cells, after CNTF <strong>in</strong>fusion, were also lept<strong>in</strong> responsive, as would beappropriate for such neurons. Mouse models of obesity, deficient <strong>in</strong> lept<strong>in</strong> orits receptor, also displayed a neurogenic response follow<strong>in</strong>g CNTF but notsusta<strong>in</strong>ed weight loss suggest<strong>in</strong>g that the latter requires lept<strong>in</strong> signall<strong>in</strong>g.CNTF-<strong>in</strong>duced neurogenesis <strong>and</strong> susta<strong>in</strong>ed weight loss was abolished afteranti-mitotic adm<strong>in</strong>istration suggest<strong>in</strong>g the two are causally related. This studyshows that neurogenesis occurs <strong>in</strong> the hypothalamus, <strong>and</strong> this can be manipulatedto produce weight changes. Thus, neurogenesis seems to be <strong>in</strong>volved <strong>in</strong>other processes other than olfaction (SVZ neurogenesis) <strong>and</strong> memory (DGneurogenesis), with wide-rang<strong>in</strong>g therapeutic implications. - WPKokoeva MV, Y<strong>in</strong> H, Flier JS.Neurogenesis <strong>in</strong> the Hypothalamus of Adult Mice: Potential Role <strong>in</strong> EnergyBalance.SCIENCE2005:310(5748);679-83.MIGRAINE: Size really mattersWWW RECOMMENDEDThe significance of patent foramen ovale (PFO) <strong>in</strong> migra<strong>in</strong>e rema<strong>in</strong>s a troubledarea. Studies show an <strong>in</strong>creased <strong>in</strong>cidence of PFO <strong>in</strong> migra<strong>in</strong>eurs comparedto controls. But a significant number of normals have a PFO, <strong>and</strong> ascl<strong>in</strong>icians we have trouble know<strong>in</strong>g what PFOs mean <strong>in</strong> migra<strong>in</strong>e <strong>and</strong> whatto do about them. This is the first study exam<strong>in</strong><strong>in</strong>g the anatomy <strong>and</strong> size ofthese right-to-left shunts. 93 consecutive patients with migra<strong>in</strong>e with aura<strong>and</strong> 93 healthy controls were studied with transoesophageal echo. A PFO wasfound <strong>in</strong> 47% of the migra<strong>in</strong>e with aura group, significantly more than the17% of controls. This is not a new f<strong>in</strong>d<strong>in</strong>g. What is novel is the f<strong>in</strong>d<strong>in</strong>g of amoderate to large shunt <strong>in</strong> 38% of the migra<strong>in</strong>e group compared to only 8%<strong>in</strong> controls. In this study, the presence of a moderate to large shunt <strong>in</strong>creased36 I <strong>ACNR</strong> • VOLUME 5 NUMBER 6 • JANUARY/FEBRUARY 2006

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!